[Federal Register: October 21, 2003 (Volume 68, Number 203)]
[Notices]               
[Page 60095]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21oc03-54]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. and Foreign Patents and Patent Applications 
Concerning Indolo [2,1-B] Quinazole-6,12-Dione Antimalarial Compounds 
and Methods of Treating Malaria

AGENCY: Department of the Army, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR Part 404.6 and 404.7, announcement 
is made of the availability for licensing of inventions set forth in 
the following, related patent applications:
    1. Title: Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial 
Compounds and Methods of Treating Malaria.
    U.S. Patent No.: 6,531,487.
    Issued: March 11, 2003.
    2. Title: Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial 
Compounds and Methods.
    U.S. Patent No.: 6,284,772.
    Issued: September 28, 1999.
    Foreign rights are also available. The United States Government, as 
represented by the Secretary of the Army, has rights in these 
inventions.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Applications, (301) 619-6664, 
both at telefax (301) 619-5034.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-26431 Filed 10-20-03; 8:45 am]

BILLING CODE 3710-08-M